Artificial intelligence news.
Straight from the original announcements.

Illumina adds AI variant ranking and workflow software to BioInsight Platform

October 21, 2026, 15:15By the AI News Bites Editorial TeamSource: PR Newswire
Illumina adds AI variant ranking and workflow software to BioInsight Platform
Image: PR Newswire

Illumina has introduced three early-access capabilities on its BioInsight Platform: DRAGEN Ultra, Workflow Orchestrator and Learning Cohorts. According to the company, they are meant to help researchers move faster from sequencing data to discovery by adding AI-driven analysis, automation and cohort exploration.

Key points
  • Illumina launched DRAGEN Ultra, Workflow Orchestrator and Learning Cohorts in early access on its BioInsight Platform.
  • Workflow Orchestrator runs connected genomic analyses across tens of thousands of samples with full result lineage.
  • DRAGEN Ultra includes the dnaAI model, which according to Illumina raised disease associations by 8% across unsolved cases.
  • dnaAI ranked established disease-associated variants in its top four candidates in 99.4% of genomes analyzed, per Illumina.
  • Learning Cohorts lets researchers build and compare cohorts across private genomic, multiomic and phenotypic data.

Three tools, one platform

Illumina, Inc. (NASDAQ: ILMN) presented the tools at the annual meeting of the American Society of Human Genetics (ASHG) in Montréal. All three are available to early access customers through the Illumina BioInsight Platform, which according to the company debuted the week before the announcement.

The platform offers a suite of genomic and multiomics software tools and data sources. Researchers can pick the capabilities they need, link them together and add more as their programs grow.

Rami Mehio, senior vice president and general manager of BioInsight at Illumina, said the company has "put all our new development energy into new capabilities to make it easy to scale insight generation, so research organizations can focus on advancing the science rather than assembling and maintaining software."

Workflow Orchestrator and DRAGEN Ultra

Workflow Orchestrator is designed to run each genomic analysis as a connected process. It covers sample tracking, sequencer run planning, secondary analysis, quality control and tertiary software for insight generation. A visual workflow builder lets customers start from an Illumina-authored template and configure parameters for their own lab. According to Illumina, the software executes the workflow consistently and compliantly across tens of thousands of samples.

Each sample keeps a single identity across software tools. The result lineage records the inputs, software versions, settings and quality metrics behind each result, which Illumina describes as a reproducible, audit-ready foundation for genomic analysis.

DRAGEN Ultra extends the DRAGEN analysis line beyond variant calling. It combines Illumina genomic AI models with proprietary knowledge resources to prioritize variants for further investigation. It runs on the BioInsight Platform as well as on customer premises, in private clouds and in air-gapped environments. Illumina says it is designed for applications such as rare disease, population genomics and multiomic studies.

DRAGEN Ultra will include dnaAI, a new variant prioritization model from the BioInsight AI Lab that predicts which variants are most likely to explain an observed phenotype. Illumina presented early research findings at a plenary session at ASHG. According to the company, applying dnaAI to large scale datasets produced an 8% increase in disease associations across unsolved cases, and the model ranked previously established disease-associated variants among its top four candidates in 99.4% of genomes analyzed. DRAGEN Ultra also draws on PrimateAI-3D, PromoterAI and the newly announced SpliceAI2.

Learning Cohorts and what it means for researchers

Learning Cohorts is meant to take researchers past single-sample evaluation. Users can explore genomic, multiomic and phenotypic data across large private sample collections, compare individual observations with broader populations and look for associations that may not be visible in any one sample. Illumina says this makes capabilities available to private researchers that were traditionally only available with large public cohorts.

In the company's example, a researcher studying a rare variant can find subjects with similar genomic features or phenotypes, compare outcomes across groups and explore associations that may warrant further study. The tool works together with the previously announced BioInsight Data, which adds curated reference datasets for enriching institutional cohorts.

For research organizations, the pitch is a connected path from sample handling to prioritized variants to population context, without stitching together separate software. All three tools are still in early access, and the source gives no details on pricing or general availability. The independent value of the dnaAI results will depend on further evaluation, since the figures come from Illumina's own early research findings.

ASHG attendees can learn more at Illumina booth #701 and at the company's Industry Education session on Friday, Oct 23, 12:15 PM to 1:15 PM (ET) in Room 513 ABC.

IlluminaBioInsight PlatformDRAGEN UltraBioInsight Platform Workflow OrchestratorBioInsight Platform Learning Cohortshealthcarescienceenterprise AI

Related news

Research
ResearchNovember 20, 2026, 02:00

Illumina Wins Virtual Cell Challenge, Powered by Billion Cell Atlas

Illumina has won the Virtual Cell Challenge, and the result was powered by the company's Billion Cell Atlas, according to a release distributed via PR Newswire on 20…

MemorialCare uses rapid technology to spot hidden brain aneurysms
Products and toolsNovember 19, 2026, 20:46

MemorialCare uses rapid technology to spot hidden brain aneurysms

MemorialCare Neuroscience Institute is using rapid aneurysm technology to spot hidden brain aneurysms, according to a PR Newswire release. The announcement describes the…

Products and tools
Products and toolsOctober 14, 2026, 15:15

Illumina launches BioInsight Platform to unify genomic analysis, AI and data

Illumina has debuted the BioInsight Platform, which the company describes as its first unified software environment for turning genomic and multiomic data into…